Curia

Scientific services, products and technologies that improve quality of life while delivering.

Launch date

1991

Employees

1001-5000 people

Market cap

Enterprise valuation

€2.6b (Public information from Sep 2024)

Albany New York (HQ)

http://amriglobal.com

https://twitter.com/curiacdmo https://www.facebook.com/curiacdmo https://www.linkedin.com/company/amri https://play.google.com/store/apps/details?id=com.voicestorm.amrifuse

Revenues, earnings & profits over time

USD	2020	2021	2022	2023	2024	2025	2026
Revenues	901m	929m	1.0b	1.1b	1.3b	1.4b	1.5b
% growth	(15 %)	3 %	11 %	11 %	12 %	6 %	6 %
EBITDA	252m	251m	254m	265m	273m	313m	376m
% EBITDA margin	28 %	27 %	25 %	23 %	21 %	23 %	26 %
Profit	99.0m	118m	96.0m	111m	115m	142m	182m
% profit margin	11 %	13 %	9 %	10 %	9 %	10 %	13 %
EV / revenue	2.8x	3.1x	3.1x	2.9x	2.5x	2.3x	2.0x
EV / EBITDA	10.0x	11.6x	12.7x	12.6x	11.6x	9.9x	7.8x

Date	Investors	Amount	Round
-	Signet Healthcare Partners	N/A	-
Feb 1999	N/A	N/A	IPO
Jan 2012	HarbourVest Partners	N/A	-
Aug 2017	GTCR	N/A	Growth Equity VC
Mar 2022	North Haven Private Income Fund	$7.0m	Debt
Total Funding		-

Tech stackLearn more about the technologies and tools that this company uses.

ACQUISITION by Curia May 2016

Oso Biopharmaceuticals Manufacturing

ACQUISITION by Curia Jun 2014

Fluorous Technologies

ACQUISITION by Curia Jul 2021

ACQUISITION by Curia Jul 2021

Cedarburg Hauser Pharmaceuticals

ACQUISITION by Curia Mar 2014

Gadea Pharmaceutical Group

ACQUISITION by Curia Jul 2015

ACQUISITION by Curia Apr 2010